Delivery Order SPE2DB20D1109-SPE2DB23FN40X
- Not listed
- The U.S. government's Defense Logistics Agency (DLA) Troop Support Medical awarded a $17,738.01 delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical used for various medical treatments. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, which provides a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $62,503.53 firm-fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of 4,559,396,013 units of Dupixent 300 mg/2 ml syringes. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which enables the agency to efficiently procure a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $34,699.56 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml syringes and has an ultimate completion date of April 15, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued at up to $999,999,999.00, which serves as the primary contract vehicle for the company to deliver...
- The Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Dupixent 300 mg/2 ml syringes. The contract, valued at $1,652.35, is a firm-fixed-price contract with a period of performance through December 27, 2023. This order is part of a larger Indefinite Delivery Contract (IDC) held by Cencora, Inc. with the DLA Troop Support Medical, valued up to $999,999,999 and running through November 2026. The IDC...
- The U.S. Defense Logistics Agency (DLA) awarded a $4,285.15 delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Dupixent 300 mg/2 ml syringes. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen's parent company, Cencora, Inc., holds with the DLA Troop Support Medical. This IDC enables the efficient procurement of a wide range of pharmaceutical products and medical supplies to...
- This is a $3,304.72 delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 200 mg/1.14 ml syringes, with a completion date of June 15, 2022. The contract has a firm fixed price pricing type and was not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $31,160.74 firm fixed-price delivery order is for the supply of Dupixent 300 mg/2 ml syringes, a specialty pharmaceutical product. The contract has a completion date of May 11, 2023. Amerisourcebergen Drug Corp holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- The U.S. government agency, the Defense Logistics Agency (DLA) Troop Support Medical, awarded a $20,002.33 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml syringes. This award is part of a larger $999,999,999.00 Indefinite Delivery Contract that Cencora, Inc. holds with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order valued at $6,577.57 to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The order is for the pharmaceutical product Dupixent 300 mg/2 ml syringe, 2 ml, with a completion date of December 6, 2023. The contract is an Indefinite Delivery Contract (IDC) with a ceiling value of $999,999,999.00, which serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $6,609.40 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the supply of Dupixent 300 mg/2 ml pen, a specialty pharmaceutical product. This delivery order contract has a final completion date of December 6, 2023 and is a firm fixed-price arrangement. The contract does not have a set-aside designation, indicating full and open competition. Amerisourcebergen Drug Corp is a major...
- SPE2DB20D1109Indefinite Delivery Contract
- SPE2DB20D1109-SPE2DB23FN40XDelivery Order
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract valued at $3,304.72 to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., for the supply of Dupixent 300 mg/2 ml syringes. This order is part of a larger Indefinite Delivery Contract (IDC) that Cencora, Inc. holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 and running through November 2026. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that supplies a wide range of medical products, including specialty medications, brand-name and generic drugs, vaccines, and medical devices, to support the healthcare needs of the U.S. military and other federal agencies.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.3k | 1/26/23 |